James Burchnall

James’ experience includes leading the Kain Lawyers teams advising:

• SILK Laser Clinics (ASX:SLA) on its acquisition by Australian Pharmaceutical Industries (API) (a subsidiary of Wesfarmers (ASX:WES)) by way of scheme of arrangement for approximately $180 million;
• Symphony Infrastructure Partners on its $488 million Series-A financing round, and on its acquisitions of RJE Global, Catalpa Group, Energy3 and Clutch;
• Kelsian Group (ASX:KLS) on its US$325 million (~A$487 million) acquisition of All Aboard America! Holdings Inc. and the associated A$281 million capital raising;
• Waveconn on its acquisition of AT Australia from American Tower Corporation (NYSE:AMT) and the acquisition of a significant portfolio of mobile tower and rooftop sites from Optus;
• Kelsian Group (ASX:KLS) on its $698 million (including up to $63 million contingent consideration) acquisition of Transit Systems Group, together with a $154 million capital raise by accelerated non-renounceable entitlement offer and placement;
• ROC Partners on its $350 million+ competitive takeover bid for Vitalharvest (ASX:VTH);
• Kelsian Group (ASX:KLS) on its $125 million acquisition of Transit Systems Marine, and the associated capital raising of $51 million, and on Kelsian’s acquisition of the Kingfisher Bay Resort Group for $43 million;
• Ellex Medical Lasers Limited (ASX:ELX) on its capital raising of $23.2 million from US and Australian institutional and sophisticated investors;
• Alcidion Group Limited (ASX:ALC) on its acquisition of MKM Health and UK-based Patientrack; and
• Stilmark Group on its bid for the Optus tower portfolio and on the sale of Stilmark to OMERS Infrastructure.